Figure 7From: 1,2-Dioleoyl-3-Trimethylammonium-Propane (DOTAP)-Formulated, Immune-Stimulatory Vascular Endothelial Growth Factor A Small Interfering RNA (siRNA) Increases Antitumoral Efficacy in Murine Orthotopic Hepatocellular Carcinoma with Liver FibrosisA simplified overview elucidating our hypothesis: siRNA uptake is improved by efficacy due to formulation with DOTAP, whereas naked VEGF-A siRNA treatment results in low uptake, inducing only limited gene knockdown and low antitumoral efficacy.Back to article page